Topical therapies for melasma and disorders of hyperpigmentation

Dermatologic Therapy

Volumn 14, Issue 1, 2001, Pages 35-45

  Jimbow, Kowichi ^a   Minamitsuji, Yasushi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemical peels; Hydroquinone; Hyperpigmentation; Melanin; Melasma

Indexed keywords

AZELAIC ACID; CORTICOSTEROID; GLYCOLIC ACID; HYDROQUINONE; KOJIC ACID; MELANIN; PHENOL DERIVATIVE; RETINOIC ACID; SALICYLIC ACID; SUNSCREEN;

ACNE VULGARIS; ARTICLE; CHLOASMA; CLINICAL FEATURE; GENETIC PREDISPOSITION; HUMAN; HYPERPIGMENTATION; MELANOCYTE; MELANOSIS; OTA NEVUS; PATHOGENESIS; PHOTODERMATOSIS; SKIN LUPUS ERYTHEMATOSUS; ULTRAVIOLET RADIATION;

EID: 0035078832     PISSN: 13960296     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1529-8019.2001.014001035.x     Document Type: Article

References (34)

1. Biology of melanocytes
2. Melasma
3. Disorders of hyperpigmentation
4. Arzneiliche und gewerbliche Dermatosen durch Kriegserzatmittel (Vaseline Schmierol) und eigenartige Melanodermatitiden
5. Relation with facial skin diseases and lipids and lipoperoxide of serum and sebum, pH on the face and buffering power
6. Riehl's melanosis and pigmentation after patch testing: Light and electron microscopic study
7. Nevus of Ota
8. A new formula for depigmenting human skin
9. Clinical and therapeutic aspects of melasma: An overview
10. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma
11. The treatment of melasma: 20% azelaic acid versus 4% hydroquinone cream
12. Short- and long-term histologic effects of topical tretinoin on photodamaged skin
13. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients
14. Retinoic acid is a potent inhibitor of inducible pigmentation in murine and hamster melanoma cell lines
15. Induction of melanogenesis suppression: Cellular pharmacology and mode of differential action
16. Effect of kojic acid on the oxidation of DLDOPA, norepinephrine, and dopamine by mushroom tyrosinase
17. N-acetyl-4-S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with malasma
18. Selective incorporation and specific cytocidal effect as the cellular basis for the antimelanoma action in sulphur containing tyrosine analogs
19. Sulphur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinase-mediated apoptosis
20. Chemical face peels
21. Glycolic acid peels for the treatment of wrinkles and photoaging
22. Glycolic acid peels in the treatment of melasma among Asian women
23. 50% Resorcinol peel
24. How we do it: Management of facial hyperpigmentation
25. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions
26. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups
27. New treatment options for the patient with facial hyperpigmentation
28. Mechanism of depigmentation by hydroquinone
29. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial
30. A new bleaching protocol for hyperpigmented skin lesions with a high concentration of all-trans retinoic acid aqueous gel
31. Treatment of melasma with Jessner's solution versus glycolic acid: A comparison of clinical efficacy and evaluation of the predictive ability of Wood's light examination
32. The in vivo melanocytotoxicity and depigmenting potency of N-2,4-acetoxyphenyl thioethyl acetamide in the skin and hair
33. Etiologic and therapeutic considerations
34. Depigmenting effects of calcium D-pantetheine-S-sulfonate on human melanocytes